We hypothesize that this might be due to transgene instability in tumor cells, promoter inactivity or silencing, or potential overgrowth by small numbers of non-expressing Tnfsf9 GB cells, rather than an effect of rIL-12 treatment. Here, TNFSF9 is linked to neoplasm.